Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection.
del Valle García-Sánchez
María
M
Gómez-Camacho
Federico
F
Poyato-González
Antonio
A
Iglesias-Flores
Eva María
EM
de Dios-Vega
Juan Francisco
JF
Sancho-Zapatero
Rocio
R
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy*; D018450:Disease Progression; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D019694:Hepatitis B, Chronic / Q000473:pathology*; D006801:Humans; D000069285:Infliximab; D008297:Male; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab